An attempt to clarify indications for hepatectomy for liver metastases from breast cancer

American Journal of Surgery

Volumn 185, Issue 2, 2003, Pages 158-164

  Elias, Dominique ^a   Maisonnette, Franck ^a   Druet Cabanac, Michel ^a   Ouellet, Jean Francois ^a   Guinebretiere, Jean Marc ^a   Spielmann, Marc ^a   Delaloge, Suzette ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Breast cancer; Hepatectomy; Hepatic arterial infusion chemotherapy; Hormone receptor status; Liver metastases; Prognostic factors

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGE; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RECURRENT DISEASE; RISK; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 0037309215     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01204-7     Document Type: Article

References (30)

1. Elias D., Lasser P.H., Spielmann M., et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet. 172:1991;461-464.
2. Schneebaum S., Walker M., Young D., et al. The regional treatment of liver metastases from breast cancer. J Surg Oncol. 55:1994;26-32.
3. Pickren J.W., Tsukada Y., Lane W.W. Liver metastasis analysis of autopsy data . Weiss L., Gilbert P. Liver metastasis. 1982;2-19 GK Hall Medical, Boston.
4. Lee Y.T. Breast carcinoma pattern of recurrence and metastasis after mastectomy . Am J Clin Oncol. 7:1984;443-449.
5. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg. 230:1999;309-321.
6. McCarter M.D., Fong Y. Role of surgical cytoreduction in multidisciplinary treatments for cancer. Ann Surg Oncol. 8:2001;38-43.
7. Raab R., Nussbaum K.T., Werner U., Pilchmayer R. Liver metastases in breast carcinoma. Results of partial liver resection. Chirurg. 67:1996;234-237.
8. Seifert J.C., Weigel T.F., Gonner U., et al. Liver resection for breast cancer metastases. Hepato-Gastroenterology. 46:1999;2935-2940.
9. Selzner M., Morse M.A., Vredenburg J.J., et al. Liver metastases from breast cancer long term survival after curative resection . Surgery. 127:2000;383-389.
10. Yoshimoto M., Tada T., Saito M., et al. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat. 127:2000;383-389.
11. Pocard M., Pouillart P., Asselain B., et al. Liver resections from breast cancer metastasis results and prognosis factors after hepatic resection in 65 cases . Ann Chir. 126:2001;413-420.
12. Bathe O.F., Kaklamanos I.G., Moffat F.L., et al. Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer. Sur Oncol. 8:1999;35-42.
13. Elias D., Lasser P.H., Montrucolli D., et al. Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol. 21:1995;510-513.
14. Piccart MJ, Awada A, Hamilton A. Integration of new therapies into management of metastatic breast cancer: a focus on chemotherapy, treatment selection through use of molecular markers and newly developed biologic therapies in late clinical development. Am Soc Clin Oncol 1999 Educational Book:526-539.
15. Kiang D.T., Kennedy B.J., Younger J., et al. Alternating chemotherapy regimens for patients with metastatic breast cancer. Cancer. 75:1995;826-830.
16. Piccart M.J. Docetaxel a new defense in the management of breast cancer . Anti-Cancer Drugs. 6:(Suppl 4):1995;7-11.
17. Pouillart P., Jouvert M., Palangie T., et al. Hepatic metastases in cancer of the breast. Analysis of parameters acting response to chemotherapy. Ann Gastroenterol Hepatol. 21:1985;87-90.
18. Nadal J.M., Jouve M., Mosseri V., et al. Cancer du sein métastatique traité par polychimiothérapie une nouvelle approche pronostique . Bull Cancer. 75:1988;757-759.
19. Aapro M.S. Combining new agents with antracyclines in metastatic breast cancer an overview of recent findings . Sem Oncol. 2:(suppl 3):1999;17-21.
20. Elias D., Cavalcanti A., Eggenspieler P., et al. Resection of liver metastases from noncolorectal primary indications and results based on 147 monocentric patients . Am J Coll Surg. 187:1998;487-493.
21. Malassagne B., Goere D., Cherqui D., Faniez P.L. Surgical treatment of non-colorectal and non-endocrine liver metastases. (review) Gastroenterol Clin Biol. 24:2000;177-185.
22. Tsavellas G., Patel H., Aleen-Mersh T.G. Detection and clinical significance of occult tumour cells in colorectal cancer. Review Br J Surg. 88:2001;1307-1320.
23. Krag D.N., Ashikaga T., Moss T.J., et al. Breast cancer cells in the blood a pilot study . Breast J. 5:1999;354-358.
24. Beitsch P., Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg. 180:2000;446-449.
25. Hansen E., Wolff N., Knuechel R., et al. Tumor cells in blood shed from the surgical field. Arch Surg. 130:1995;387-393.
26. Oefelein M.G., Kauk K., Herz B., et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urology. 155:1996;238-242.
27. Pollock R.E., Roth J.A. Cancer-induced immunosuppression implications for therapy? Sem Surg Oncol. 5:1989;414-419.
28. Kavanaugh D.Y., Carbone D.P. Immunologic dysfunction in cancer. Hematol Oncol Clin North Am. 10:1996;927-951.
29. Muss H.B. Chemotherapy of gynecologic cancer. 2nd ed:1990;Wiley-Liss, New York.
30. McDonald M.L., Deschamps C., Ilstrup D.M., et al. Pulmonary resection for metastatic breast cancer. Ann Thorac Surg. 58:1994;1599-1602.